BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6936573)

  • 1. HLA-DR antigens in tuberculoid and lepromatous leprosy.
    Rea TH; Terasaki PI
    Lepr Rev; 1980 Jun; 51(2):117-23. PubMed ID: 6936573
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitation of HLA-DR expression by cells involved in the skin lesions of tuberculoid and lepromatous leprosy.
    Collings LA; Tidman N; Poulter LW
    Clin Exp Immunol; 1985 Jul; 61(1):58-66. PubMed ID: 3862470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the immunogenetic background of Japanese leprosy patients by the HLA system.
    Izumi S; Sugiyama K; Matsumoto Y; Ohkawa S
    Vox Sang; 1982; 42(5):243-7. PubMed ID: 6954762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique expression of HLA-DR (Ia-like) antigen in the lesions of polar tuberculoid leprosy.
    Ridley MJ; Ridley DS
    Lepr Rev; 1982 Dec; 53(4):249-52. PubMed ID: 6759822
    [No Abstract]   [Full Text] [Related]  

  • 5. HLA-linked control of predisposition to lepromatous leprosy.
    van Eden W; Gonzalez NM; de Vries RR; Convit J; van Rood JJ
    J Infect Dis; 1985 Jan; 151(1):9-14. PubMed ID: 3880800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between human leukocyte antigens and leprosy in the Turkish population.
    Koçak M; Balci M; Pençe B; Kundakçi N
    Clin Exp Dermatol; 2002 May; 27(3):235-9. PubMed ID: 12072016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions.
    Modlin RL; Kato H; Mehra V; Nelson EE; Fan XD; Rea TH; Pattengale PK; Bloom BR
    Nature; 1986 Jul 31-Aug 6; 322(6078):459-61. PubMed ID: 2942780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The involvement of dendritic cells in the cutaneous lesions associated with tuberculoid and lepromatous leprosy.
    Collings LA; Waters MF; Poulter LW
    Clin Exp Immunol; 1985 Dec; 62(3):458-67. PubMed ID: 3910315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cutaneous infiltrates of leprosy: cellular characteristics and the predominant T-cell phenotypes.
    Van Voorhis WC; Kaplan G; Sarno EN; Horwitz MA; Steinman RM; Levis WR; Nogueira N; Hair LS; Gattass CR; Arrick BA; Cohn ZA
    N Engl J Med; 1982 Dec; 307(26):1593-7. PubMed ID: 6216407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro studies on the effect of levamisole in lepromatous leprosy.
    Birdi TJ; Mistry NF; Mahadevan PR; Antia NH
    J Clin Lab Immunol; 1984 Feb; 13(2):93-6. PubMed ID: 6374154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for the presence of M. leprae reactive T lymphocytes in patients with lepromatous leprosy.
    Nath I; Sathish M; Jayaraman T; Bhutani LK; Sharma AK
    Clin Exp Immunol; 1984 Dec; 58(3):522-30. PubMed ID: 6391762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-linked control of susceptibility to tuberculoid leprosy and association with HLA-DR types.
    de Vries RR; Mehra NK; Vaidya MC; Gupte MD; Meera Khan P; Van Rood JJ
    Tissue Antigens; 1980 Oct; 16(4):294-304. PubMed ID: 7008255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of HLA specificity LB-E12 (MB1, DC1, MT1) with lepromatous leprosy in a Venezuelan population.
    Ottenhoff TH; Gonzalez NM; de Vries RR; Convit J; van Rood JJ
    Tissue Antigens; 1984 Jul; 24(1):25-9. PubMed ID: 6592792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen specific macrophage-lymphocyte interaction in lepromatous leprosy.
    Birdi TJ; Mistry NF; Mahadevan PR; Antia NH
    J Clin Lab Immunol; 1984 Apr; 13(4):189-94. PubMed ID: 6376810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells.
    Ottenhoff TH; Elferink DG; Klatser PR; de Vries RR
    Nature; 1986 Jul 31-Aug 6; 322(6078):462-4. PubMed ID: 2426597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leprosy associated with HLA-DR2 and DQw1 in the population of northern Thailand.
    Schauf V; Ryan S; Scollard D; Jonasson O; Brown A; Nelson K; Smith T; Vithayasai V
    Tissue Antigens; 1985 Oct; 26(4):243-7. PubMed ID: 3878012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occasional review--HLA and leprosy: a re-evaluation.
    van Eden W; de Vries RR
    Lepr Rev; 1984 Jun; 55(2):89-104. PubMed ID: 6431213
    [No Abstract]   [Full Text] [Related]  

  • 18. An immunoperoxidase study of immunological factors in high immune and low resistance granulomas in leprosy.
    Ridley MJ; Russell D
    J Pathol; 1982 Jun; 137(2):149-57. PubMed ID: 7045310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of delayed immune reactions on human epidermal keratinocytes.
    Kaplan G; Witmer MD; Nath I; Steinman RM; Laal S; Prasad HK; Sarno EN; Elvers U; Cohn ZA
    Proc Natl Acad Sci U S A; 1986 May; 83(10):3469-73. PubMed ID: 3085090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of the HLA class II frequency alleles in patients with leprosy from the mid-west of Brazil.
    Lavado-Valenzuela R; José Bravo M; Junqueira-Kipnis AP; Ramos de Souza M; Moreno C; Alonso A; Liberman-Kipnis T; da Silva WD; Caballero A
    Int J Immunogenet; 2011 Jun; 38(3):255-8. PubMed ID: 21599852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.